The "Tamiflu" medication instructions for use are presented as an antiviral agent that is part of a group of pro-drugs. This drug is based on competitive and selective inhibition of neuraminidase of pathogenic influenza A and B organisms. This process is due to the catalyzed release of the virus from infected cells and its penetration into the respiratory system epithelial cells. As a result of using the "Tamiflu" (application instruction is necessarily attached), further spread of bacteria in the body is blocked. When taking this medication for the purpose of prevention, the risk of influenza infection in contacting persons is significantly reduced, and the transmission of infection from one member of the family to another is prevented. You can buy this antiviral medicine today in almost every pharmacy, the cost of Tamiflu is about 1000-1100 rubles.
This preparation is produced in the form of gelatin capsules and in the form of a powder intended for the preparation of a suspension for further ingestion. As an active ingredient, oseltamivir is included in the drug. Capsules contain it in a volume of 75 mg, and the powder in a volume of 30 mg. The composition of the pills also additionally includes such substances as: povidone K30, talc, pregelatinized starch, sodium fumarate stearyl and croscarmellose sodium. Powder as auxiliary ingredients contains sorbitol, xanthan gum, Permatil Tutti-Frutti and titanium dioxide. In addition, it contains a small amount of monosodium citrate, sodium benzoate and saccharin sodium.
Take the drug "Tamiflu" instruction for use recommends for the treatment of influenza in both adults and children older than one year. In addition, this drug is actively prescribed to prevent viral infections in patients of different age categories. Quite often this drug is used to prevent influenza in people working in large production teams, in military units or simply with weakened immunity.
Take this antiviral drug categorically prohibited in the case of individual intolerance to oseltamivir or an allergic reaction to any of its other components. People suffering from chronic kidney failure should also refrain from taking Tamiflu capsules. An antiviral drug should not be taken while the child is pregnant. Women who breastfeed should also give up this medication.
As for adverse reactions, as a rule, patients complain of vomiting and nausea in the first few days of taking the drug. In addition, abdominal pain, diarrhea, dizziness, weakness, cough and bronchitis due to the use of Tamiflu can be observed. Instructions for use indicate a risk of sleep disturbances, development of dyspepsia and rhinorrhea.